Is neoadjuvant treatment indicated in triple negative cT1N0 breast cancer? Garcia-Torralba; Noel Blaya Boluda; María Esperanza Guirao García; Elisa García Garre; Francisco Ayala de la Peña;

The role of artificial intelligence integrating multi-omics in breast cancer Gomez-Bravo; Benjamín Walbaum; Elia Segui; Munoz;

How can we integrate current adjuvant treatment options in triple negative patients with residual disease after neoadjuvant treatment? Mª. Teresa Quintanar-Verdúguez; María Ballester Espinosa; Javier Pérez-Altozano; Álvaro Muñoz-Abad; Álvaro Rodríguez-Lescure;